Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported questionnaires?

References

• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97
   PubMed Web of Science ®Google Scholar
• Sabate E. World Health Organization: Adherence to Long-term Therapies – Evidence for Action. Geneva: WHO Publications, 2003
   Google Scholar
• Vrijens B, de Geest S, Hughes DA, et al. ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73:691-705
   PubMed Web of Science ®Google Scholar
• Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med 2010;25:284-90
   PubMed Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication Adherence Measures: An Overview. BioMed Research International 2015:217047
   PubMed Web of Science ®Google Scholar
• Solomon MD, Majumdar SR. Primary non-adherence of medications: lifting the veil on prescription-filling behaviors. J Gen Intern Med 2010;25:280-1
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47:555-67
   PubMed Web of Science ®Google Scholar
• Kubica A, Grześk G, Sinkiewicz W, et al. Compliance, concordance, adherence in chronic therapy. Folia Cardiol Excerpta 2010;5:54-7
   Google Scholar
• Kubica A, Kochman W, Bogdan M, et al. The influence of undergone percutaneous coronary interventions, and earlier hospitalizations with myocardial infarction on the level of knowledge and the effectiveness of health education in patients with myocardial infarction. Adv Intervent Cardiol 2009;5:25-30
   Google Scholar
• DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004;42:200-9
   PubMed Web of Science ®Google Scholar
• Singh N, Squier C, Sivek C, et al. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 1996;8:261-9
   PubMed Web of Science ®Google Scholar
• Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 2004;4:191-5
   PubMed Web of Science ®Google Scholar
• Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. JAPhA 2011;51:90-4
   Google Scholar
• Svarstad BL, Chewning BA, Sleath BL, et al. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999;37:113-24
   PubMed Web of Science ®Google Scholar
• Canpolat U, Yorgun H, Atalar E. Simultaneous subacute thrombosis of bare metal coronary stents in two different arteries early after clopidogrel cessation. Cardiol J 2012;19:309-13
   PubMed Web of Science ®Google Scholar
• Ho PM, Tsai TT, Maddox TM, et al. Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care. Circ Cardiovasc Qual Outcomes 2010;3:261-6
   PubMed Web of Science ®Google Scholar
• Jeremias A, Sylvia B, Bridges J Jr, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004;109:1930-32
   PubMed Web of Science ®Google Scholar
• Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30
   PubMed Web of Science ®Google Scholar
• Kubica A, Kasprzak M, Obońska K, et al. Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction. Pharmacology 2015;95:50-8
   PubMed Web of Science ®Google Scholar
• Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113:2803-9
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1-34
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535
   PubMed Web of Science ®Google Scholar
• Kubica A, Obońska K, Fabiszak, et al. Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials. Curr Med Res Opin 2016;32:1441-51
   PubMed Web of Science ®Google Scholar
• Kubica A, Kasprzak M, Siller-Matula J, et al. Time-related changes in determinants of antiplatelet effect of clopidogrel in patients after myocardial infarction. Eur J Pharmacol 2014;742:47-54
   PubMed Web of Science ®Google Scholar
• Ferreira-González I, Marsal JR, Ribera A, et al. Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year. J Am Coll Cardiol 2012;60:1333-9
   PubMed Web of Science ®Google Scholar
• Ferreira-Gonzalez I, Marsal JR, Ribera A, et al. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation. Circulation 2010;122:1017-25
   PubMed Web of Science ®Google Scholar
• Sengstock D, Vaitkevicius P, Salama A, et al. Under-prescribing and non-adherence to medications after coronary bypass surgery in older adults: strategies to improve adherence. Drugs Aging 2012;29:93-103
   PubMed Web of Science ®Google Scholar
• Tuppin P, Neumann A, Danchin N, et al. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization. Arch Cardiovasc Dis 2010;103:363-75
   PubMed Web of Science ®Google Scholar
• Muntner P, Mann DM, Woodward M, et al. Predictors of low clopidogrel adherence following percutaneous coronary intervention. Am J Cardiol 2011;108:822-7
   PubMed Web of Science ®Google Scholar
• Kubica A, Obońska K, Kasprzak M, et al. Prediction of high risk of non-adherence to antiplatelet treatment. Kardiol Pol 2016;74:61-7
   PubMed Web of Science ®Google Scholar
• Vitolins MZ, Rand CS, Rapp SR, et al. Measuring adherence to behavioral and medical interventions. Control Clin Trials 2000;21(Suppl):188-94S
   PubMedGoogle Scholar
• Kubica A. Collaboration with the patient – a basic condition of therapy effectiveness in coronary artery disease. Chor Serca Nacz 2009;6:131-4
   Google Scholar
• Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998;36:1138-61
   PubMed Web of Science ®Google Scholar
• McDonnell PJ, Jacobs MR, Monsanto HA, et al. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002;36:1331-6
   PubMed Web of Science ®Google Scholar
• Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Therapeut 1999;21:1074-90
   PubMed Web of Science ®Google Scholar
• Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009;119:3028-35
   PubMed Web of Science ®Google Scholar
• Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J 2011;26:155-9
   PubMedGoogle Scholar
• Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001;26:331-42
   PubMed Web of Science ®Google Scholar
• Shi L, Liu J, Fonseca V, et al. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes 2010;8:99
   PubMed Web of Science ®Google Scholar
• Perez-Escamilla B, Franco-Trigo L, Moullin JC, et al. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence 2015;9:569-78
   PubMed Web of Science ®Google Scholar
• Siller-Matula JM, Trenk D, Krähenbühl S, et al. Clinical implications of drug–drug interactions with P2Y12 receptor inhibitors. J Thromb Haemost 2014;12:2-13
   PubMed Web of Science ®Google Scholar
• Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150:1509-10
   PubMed Web of Science ®Google Scholar
• Modi AC, Ingerski LM, Rausch JR, et al. White coat adherence over the first year of therapy in pediatric epilepsy. J Pediat 2012;161:695-9
   PubMed Web of Science ®Google Scholar
• Dew MA, Dabbs AD, Myaskovsky L, et al. Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation 2009;88:736-46
   PubMed Web of Science ®Google Scholar
• Matsui D, Hermann C, Klein J, et al. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol 1994;34:944-9
   PubMed Web of Science ®Google Scholar
• Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-16
   PubMed Web of Science ®Google Scholar
• Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006;15:565-74
   PubMed Web of Science ®Google Scholar
• Adamski P, Ostrowska M, Sikora J, et al. Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study. BMJ Open 2017;7:e013218
   PubMed Web of Science ®Google Scholar
• Kubica A. Problems of long-term antiplatelet therapy after coronary stent implantation. Adv Intervent Cardiol 2009;5:158-61
   Google Scholar
• Kubica A, Obońska K, Kasprzak M, et al. The impact of metabolic syndrome on the antiplatelet effect of clopidogrel and aspirin in patients with acute coronary syndrome. Folia Med Copernicana 2014;2:66-72
   Google Scholar
• Kubica A, Koziński M, Grześk G, et al. Genetic determinants of platelet response to clopidogrel. J Thromb Thrombolysis 2011;32:459-66
   PubMed Web of Science ®Google Scholar
• Siller-Matula JM, Specht S, Kubica J, et al. Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients. Br J Clin Pharmacol 2016;82:1343-50
   PubMed Web of Science ®Google Scholar
• Adamski P, Sikora J, Laskowska E, et al. Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: a prospective, observational, single-centre study. PLoS One 2017;12:e0186013,1-12
   PubMed Web of Science ®Google Scholar
• Kubica J, Adamski P, Buszko K, et al. Rationale and design of the effectiveness of lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA) pilot study. Eur Heart J Cardiovasc Pharmacother 2018;4:152-157
   PubMed Web of Science ®Google Scholar
• Winter MP, Grove EL, De Caterina R, et al. Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors. Eur Heart J Cardiovasc Pharmacother 2017;3:221-34
   PubMed Web of Science ®Google Scholar
• Siller-Matula JM, Hintermeier A, Kastner J, et al. Distribution of clinical events across platelet aggregation values in all-comers treated with prasugrel and ticagrelor. Vascul Pharmacol 2016;79:6-10
   PubMed Web of Science ®Google Scholar
• Winter MP, Koziński M, Kubica J, et al. Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls. Adv Intervent Cardiol 2015;11:259-80
   Google Scholar
• Siller-Matula JM, Akca B, Neunteufl T, et al. Inter-patient variability of platelet reactivity in patients treated with prasugrel and ticagrelor. Platelets 2016;27:373-7
   PubMed Web of Science ®Google Scholar
• Garber MC, Nau DP, Erickson SR, et al. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004;42:649-52
   PubMed Web of Science ®Google Scholar
• Cook CL, Wade WE, Martin BC, et al. Concordance among three self-reported measures of medication adherence and pharmacy refill records. JAPhA 2005;45:151-9
   Google Scholar
• Velligan DI, Wang M, Diamond P, et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatric Services 2007;58:1187-92
   PubMed Web of Science ®Google Scholar
• Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004;38:303-12
   PubMed Web of Science ®Google Scholar
• Wang PS, Benner JS, Glynn RJ, et al. How well do patients report noncompliance with antihypertensive medications? A comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf 2004;13:11-19
   PubMed Web of Science ®Google Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Therapeut 2001;23:1296-310
   PubMed Web of Science ®Google Scholar
• Lamprea JAM, Gómez Restrepo C. Validez en la evaluación de escalas [Validity in scale-testing]. Rev Colomb Psiquiat 2007;36:340-8
   Google Scholar
• Sánchez Pedraza R, Gómez Restrepo CI. Conceptos básicos sobre validación de escalas. [Basic concepts on validation]. Spanish. Rev Colomb Psiquiat 1998;27:121-30
   Google Scholar
• Polit DF, Beck CT. Assessing data quality. In: Nursing Research. Principles and Methods, 7th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 1995:413-48
   Google Scholar
• Frost MH, Reeve BB, Liepa AM, et al. Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health 2007;10(Suppl 2):S94-S105
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74
   PubMed Web of Science ®Google Scholar
• Ben AJ, Neumann CR, Mengue SS. The Brief Medication Questionnaire and Morisky–Green test to evaluate medication adherence. Rev Saude Publica 2012;46:279-89
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Muntner P, Jannu A, et al. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci 2005;330:128-33
   PubMed Web of Science ®Google Scholar
• Kim MT, Hill MN, Bone LR, et al. Development and testing of the Hill–Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs 2000;15:90-6
   PubMedGoogle Scholar
• Lambert EV, Steyn K, Stender S, et al. Cross-cultural validation of the Hill–Bone Compliance to High Blood Pressure Therapy Scale in a South African, primary healthcare setting. Ethn Dis 2006;16:286-91
   PubMed Web of Science ®Google Scholar
• Song Y, Han HR, Song HJ, et al. Psychometric evaluation of Hill–Bone medication adherence subscale. Asian Nurs Res 2011;5:183-8
   PubMed Web of Science ®Google Scholar
• Korb-Savoldelli V, Gillaizeau F, Pouchot J, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens (Greenwich) 2012;14:429-34
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008;10:348-54
   PubMed Web of Science ®Google Scholar
• Saleem F, Hassali MA, Shafie AA, et al. Translation and validation study of Morisky Medication Adherence Scale (MMAS): the Urdu version for facilitating person-centered healthcare in Pakistan. Int J Pers Cent Med 2012;2:384-90
   Google Scholar
• Ma C, Chen S, You L, et al. Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with Hypertension. J Adv Nurs 2012;68:1402-13
   PubMed Web of Science ®Google Scholar
• Martin AL, Bayarre Vea HD, Grau Ábalo JA. Validation of MBG Questionnaire (Martin–Bayarre–Grau) for the evaluation of therapy adherence in blood hypertension patients. Rev Cuba Salud Publica 2008:34
   Google Scholar
• Martínez JW, Villa Perea JA, Jaramillo J, et al. Validación del cuestionario de adherencia al tratamiento anti hipertensivo Martín Bayarré Grau. [Validation of a scale of adherence treatment antihypertensive: Martin Bayarre Grau Test]. Rev Med Risaralda 2011;17:101-5
   Google Scholar
• Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the self-efficacy for appropriate medication use scale (SEAMS) in low-literacy patients with chronic disease. J Nurs Meas 2007;15:203-19
   PubMedGoogle Scholar
• Krass I, Taylor S, Smith C, et al. Impact of medication use and adherence of Australian pharmacists diabetes care services. J Am Pharm Assoc 2004;45:33-40
   Google Scholar
• Rickles N, Svarstad B. Relationships between multiple self-reported nonadherence measures and pharmacy records. Res Social Adm Pharm 2005;3:363-77
   Google Scholar
• Pandey A, Raza F, Velasco A, et al. Comparison of Morisky Medication Adherence Scale with therapeutic medication monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens 2015;9:420-6
   PubMed Web of Science ®Google Scholar
• Marcum Z, Zheng Y, Perera S, et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. Res Social Adm Pharm 2013;9:817-27
   PubMed Web of Science ®Google Scholar
• Kripalani S, Schmotzer B. Improving Medication Adherence through Graphically Enhanced Interventions in Coronary Heart Disease (IMAGE-CHD): a randomized controlled trial. J Gen Intern Med 2012;27:1609-17
   PubMed Web of Science ®Google Scholar
• Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother 2009;43:950-7
   PubMed Web of Science ®Google Scholar
• Kubica A, Kosobucka A, Michalski P, et al. The Adherence in Chronic Diseases Scale – a new tool to monitor implementation of a treatment plan. Folia Cardiol 2017;12:19-26
   Google Scholar
• Buszko K, Obońska K, Michalski P, et al. The Adherence Scale in Chronic Diseases (ASCD). The power of knowledge: the key to successful patient–health care provider cooperation. Med Res J 2016;1:37-42
   Google Scholar
• Kosobucka A, Michalski P, Pietrzykowski Ł, et al. Adherence to treatment in patients after myocardial infarction assessed with the Adherence in Chronic Diseases Scale. Patient Prefer Adher 2018;12:333-40
   PubMed Web of Science ®Google Scholar
• Kubica A, Kosobucka A, Michalski P, et al. Self-reported questionnaires for assessment adherence to treatment in patients with cardiovascular diseases. Med Res J 2017;2:115-22
   Google Scholar